SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-10-023038
Filing Date
2010-05-25
Accepted
2010-05-25 16:37:49
Documents
1
Period of Report
2010-05-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 12582
  Complete submission text file 0001140361-10-023038.txt   14435
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA TESSERETE, 10 LUGANO V8 V8
Business Address
CAVAZZA PAOLO (Reporting) CIK: 0001163608 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15070 | Film No.: 10857331